Harry H Mansbach 89bio, Inc. (ETNB) insider trading activity

Harry H Mansbach is Chief Medical Officer of 89bio, Inc.. Currently has a direct ownership of 310,336 shares of ETNB, which is worth approximately $3.11 Million. The most recent transaction as insider was on Nov 15, 2022, when has been sold 3,113 shares (Common Stock) at a price of $9.79 per share, resulting in proceeds of $30,476. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 310K

2.67% 3M change

95.87% 12M change

Total Value Held $3.11 Million

Harry H Mansbach Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2022	SELL Payment of exercise price or tax liability	$30,476 $9.79 p/Share	3,113 Reduced 4.33%	68,838 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	-	9,000 Added 11.12%	71,951 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$16,600 $5.76 p/Share	2,882 Reduced 4.38%	62,951 Common Stock
Sep 28 2022	BUY Grant, award, or other acquisition	-	8,333 Added 11.24%	65,833 Common Stock
Sep 09 2022	BUY Grant, award, or other acquisition	-	25,000 Added 30.3%	57,500 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	22,500 Added 40.91%	32,500 Common Stock
Feb 05 2022	SELL Payment of exercise price or tax liability	$7,128 $5.23 p/Share	1,363 Reduced 4.19%	31,137 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	10,000 Added 50.0%	10,000 Common Stock

HHM

Harry H Mansbach

Chief Medical Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Value

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to 89bio, Inc.

Track Activities on ETNB

Account